SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-050539
Filing Date
2013-06-21
Accepted
2013-06-21 08:24:23
Documents
11
Period of Report
2013-06-19
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-15313_18k.htm 8-K 107104
2 EX-10.1 a13-15313_1ex10d1.htm EX-10.1 174824
3 EX-10.2 a13-15313_1ex10d2.htm EX-10.2 195380
4 EX-16.1 a13-15313_1ex16d1.htm EX-16.1 8445
5 EX-99.1 a13-15313_1ex99d1.htm EX-99.1 18102
6 EX-99.2 a13-15313_1ex99d2.htm EX-99.2 17051
7 GRAPHIC g153131moi001.jpg GRAPHIC 5569
8 GRAPHIC g153131moi002.jpg GRAPHIC 5024
9 GRAPHIC g153131kui001.jpg GRAPHIC 1881
10 GRAPHIC g153131mmi001.jpg GRAPHIC 5719
11 GRAPHIC g153131mmi002.jpg GRAPHIC 5166
  Complete submission text file 0001104659-13-050539.txt   555564
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 13925875
SIC: 2836 Biological Products, (No Diagnostic Substances)